gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

Neuro-Oncology: Psychology & Varia

Meeting Abstract (P189)

Malignant transformation of an intracranial dermoid tumour into a squamous cell carcinoma

Mursch K, Nerntengian N, Brück W, Behnke-Mursch J
[Full Text]
Meeting Abstract (P190)

The combination of tranylcypromine, riluzole and retinoic acid reveals a significant effect on glioblastoma cell viability

Sachkova A, Sperling S, Ninkovic M, Rohde V
[Full Text]
Meeting Abstract (P191)

In vitro system to dissect the molecular basis of vanilloid/TRPV1 mediated anti-tumoral activity of human neural progenitor cells in GBM

Azmitia L, Uyar R, Kälin R, Brändl B, Müller F, Glass R, Synowitz M
[Full Text]
Meeting Abstract (P192)

Experimental approach to assess mood-related behavior in Glioblastoma

Unteroberdörster M, Vogelsang M, Lückemann L, Martinez-Gomez EM, Kirchhof J, Schedlowski M, Sure U, Hadamitzky M
[Full Text]
Meeting Abstract (P193)

The expression of death receptor 6 (DR6) is upregulated in gliomas

Timmer M, Stegmann S, Werner JM, Kuhl S, Krischek B, Goldbrunner R
[Full Text]
Meeting Abstract (P194)

Galectin-1 expression in human glioblastoma specimens with regard to clinical outcome

Goett H, Stein M, Kolodziej M, Koch C, Schwarm F, Uhl E
[Full Text]
Meeting Abstract (P195)

Study proposal for immunosuppressive, adenosine-producing lymphocyte subsets in glioblastoma patients

Ziebart A, Hoffmann T, Seiz-Rosenhagen M, Ratliff M, Hänggi D, Schuler P
[Full Text]
Meeting Abstract (P196)

Optical barcoding reveals immunoediting of the clonal architecture and modulation of gene expression signatures in a syngeneic glioma model

Mohme M, Maire C, Riecken K, Dührsen L, Westphal M, Lamszus K
[Full Text]
Meeting Abstract (P197)

Quantification of the MGMT promoter methylation in glioblastoma relapse

Feldheim J, Hagemann C, Kessler AF, Monoranu CM, Linsenmann T, Ernestus RI, Löhr M
[Full Text]
Meeting Abstract (P198)

Is a circumscribed lesion-oriented resection of focal cortical dysplasia sufficient?

Kogias E, Egger K, Nakagawa JM, Scheiwe C, Urbach H, Zentner J, Schulze-Bonhage A
[Full Text]
Meeting Abstract (P199)

Differential diagnosis of thoracic meningioma: thoracic manifestation of inflammatory pseudotumor

Giese S, Fingerle-Ramina K, Naros G, Adib SD
[Full Text]
Meeting Abstract (P200)

The role of dorsal decompression without stabilization in patients with symptomatic spine metastases

Müller M, Abusabha Y, Steiger HJ, Ahmadi AS, Bostelmann R
[Full Text]
Meeting Abstract (P201)

Case series meningeal melanocytoma – “Chameleon in the spinal canal”

Schneider M, Coburger J, Schmitz B, Wirtz CR
[Full Text]
Meeting Abstract (P202)

Pregnancy in brain tumor patients

Forster MT, Harter P, Seifert V, Franz K
[Full Text]
Meeting Abstract (P203)

Glioma patients in the outpatient setting: optimizing the assessment of distress and unmet needs – results of 50 structured interviews and an expert analysis

Voß H, Renovanz M, Coburger J, Scholz-Kreisel P, Ringel F, Singer S
[Full Text]
Meeting Abstract (P204)

Intra- and interindividual differences in quality of life and preference perception in patients with eloquent intracranial tumors

Butenschön V, Maurer S, Pircher T, Ille S, Sollmann N, Meyer B, Krieg S
[Full Text]
Meeting Abstract (P205)

Montreal Cognitive Assessment (MoCA) test as a screening instrument for cognitive deficits in patients with primary brain tumors – first results of a prospective investigation

Grübel N, Renovanz M, Coburger J, Wirtz CR
[Full Text]